Antibody neutralizing SARS-CoV-2 is highly predictive of immune protection7 and correlates with anti-S1 antibody levels, which can be measured using an established platform; therefore, anti-S1 antibody levels are a good biomarker of host defense through humoral immunity against SARS-CoV-2 infection8. Here, PSMD1 is linked to COVID-19.